ArticleOncoTargets and therapy2021

A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker for Survival and Sorafenib Resistance in Liver Cancer.

Mingyi Ju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.